ZEB1 and osteosarcoma: Similarly, a recent study provided a range of evidence that highlighted the potential roles of PCAT6: it could not only serve as a valuable prognostic indicator for patients with osteosarcoma (OS), but also aggravate the malignant phenotype of OS cells via the regulation of the miR-143-3p/ZEB1 axis [25].